Genetics Terms Starting With T

Telomere is a repetitive DNA sequence and associated proteins that caps the ends of linear chromosomes, protecting them from degradation and preventing recognition as double-strand breaks.

Human telomeres consist of thousands of repetitions of the TTAGGG hexanucleotide sequence, bound by a specialized protein complex called shelterin. Because conventional DNA polymerase cannot fully replicate the ends of linear chromosomes, telomeres shorten with each cell division until they reach a critical length that triggers cellular senescence or apoptosis. Cancer cells usually reactivate the enzyme telomerase to maintain telomere length, achieving replicative immortality.

At birth, human telomeres average roughly 10,000 base pairs in length, and this length declines by approximately 20 to 40 base pairs per year in most somatic tissues.

TERT is the gene encoding the catalytic reverse transcriptase subunit of telomerase, the ribonucleoprotein enzyme that extends telomeric DNA repeats at chromosome ends to compensate for replication-associated shortening.

TERT uses the RNA component of telomerase, encoded by TERC, as a template to add TTAGGG repeats onto telomere ends. Expression of TERT is silenced in most somatic cells after development, causing progressive telomere shortening with each cell division. Reactivation of TERT expression is found in approximately 90 percent of all human cancers and is required for the indefinite proliferation of cancer cells.

Germline mutations in TERT cause dyskeratosis congenita and familial pulmonary fibrosis by impairing telomerase activity in stem cell populations that depend on continuous self-renewal.

Test Cross is a mating between an individual of unknown genotype and a homozygous recessive individual, used to determine whether the unknown individual is homozygous dominant or heterozygous.

If the unknown individual is homozygous dominant, all offspring of the test cross will show the dominant phenotype. When the unknown individual is heterozygous, approximately half the offspring will show the dominant phenotype and half the recessive phenotype. Gregor Mendel used test crosses systematically in his pea plant experiments during the 1860s to confirm that F1 plants showing the dominant phenotype were truly heterozygous, providing the empirical foundation for his law of segregation.

This approach remains a standard tool in classical genetics for determining genotype at loci showing complete dominance.

Thymine is a pyrimidine nitrogenous base found exclusively in DNA, where it pairs with adenine through two hydrogen bonds as one of the four standard DNA bases.

Thymine is distinguished from uracil, its RNA counterpart, by the presence of a methyl group at the 5-carbon position of the pyrimidine ring. Erwin Chargaff’s rules, established in the late 1940s, state that the molar amount of thymine in any DNA molecule equals the molar amount of adenine, reflecting strict complementary base pairing in the double helix. Ultraviolet radiation commonly induces the formation of thymine dimers between adjacent thymine bases on the same strand, a major form of DNA damage repaired by nucleotide excision repair.

Individuals with xeroderma pigmentosum carry inherited defects in this repair pathway and accumulate thymine dimers at a rate that causes a dramatically elevated risk of skin cancer.

Transcription is the process by which an RNA molecule is synthesized from a DNA template by RNA polymerase, producing a complementary RNA copy of the gene sequence.

During transcription, RNA polymerase unwinds a short segment of the DNA double helix and reads the antisense strand to synthesize a complementary RNA in the 5-prime to 3-prime direction. In eukaryotes, the primary transcript is processed by 5-prime capping, 3-prime polyadenylation, and splicing before export from the nucleus as mature mRNA. Transcription is the primary regulatory step controlling which genes are expressed in a given cell at a given time, and a single gene can be transcribed at rates ranging from fewer than one mRNA per hour to several thousand mRNAs per hour depending on promoter strength and transcription factor availability.

Transcriptomics is the large-scale study of all RNA transcripts produced by a genome in a specific cell, tissue, or organism under defined conditions, revealing which genes are expressed and at what levels.

RNA sequencing is the primary transcriptomic technology, quantifying thousands of transcripts simultaneously with single-nucleotide resolution. Transcriptomic data capture the dynamic response of gene expression to developmental stage, disease state, drug treatment, or environmental stimulus. Single-cell transcriptomics profiles gene expression in individual cells, revealing heterogeneity within tissues previously assumed to be homogeneous.

A landmark 2022 Human Cell Atlas study catalogued gene expression across more than 500 cell types spanning 33 human organs, demonstrating how profoundly expression patterns differ even among closely related cell populations.

Transfer RNA is a small non-coding RNA molecule that carries a specific amino acid to the ribosome during translation and base-pairs with the corresponding mRNA codon through its anticodon loop.

Each tRNA is covalently charged with its specific amino acid by an aminoacyl-tRNA synthetase enzyme in a highly accurate recognition process. The anticodon at one end of the tRNA base-pairs with the complementary mRNA codon at the ribosomal A site, ensuring the correct amino acid is added to the growing polypeptide. Humans encode 46 distinct tRNA gene families that collectively serve all 20 amino acids, with wobble base pairing at the third codon position allowing a single tRNA to recognize multiple synonymous codons.

At roughly 73 to 93 nucleotides in length, tRNA molecules are among the shortest functional RNAs in the cell.

Translation is the process by which the nucleotide sequence of a messenger RNA is decoded by ribosomes and used to assemble a specific sequence of amino acids into a polypeptide chain.

Translation occurs in three stages: initiation, elongation, and termination. During initiation, the small ribosomal subunit scans the mRNA for the AUG start codon, then recruits the large subunit to form a complete ribosome. Elongation proceeds as aminoacyl-tRNAs deliver amino acids in the order specified by successive mRNA codons, with the ribosome catalyzing peptide bond formation at roughly 15 to 20 amino acids per second in bacteria.

Multiple ribosomes can translate a single mRNA simultaneously, forming a polysome that dramatically increases the rate of protein output from one transcript.

Transposon is a DNA sequence that can move to a new location within a genome either by excising and reinserting itself or by copying itself through an RNA intermediate.

Class I retrotransposons copy themselves through a reverse transcriptase enzyme that synthesizes DNA from an RNA intermediate, a copy-and-paste mechanism that can increase total copy number in the genome with each cycle. DNA transposons of Class II move directly via a transposase enzyme that catalyzes excision and reinsertion, a cut-and-paste mechanism that does not increase copy number unless the excision gap is repaired by copying the intact allele. In the human genome, approximately 45 percent of the total sequence consists of transposon-derived elements: LINE elements account for 21 percent, SINE elements for 13 percent, LTR retrotransposons for 8 percent, and DNA transposons for about 3 percent of the haploid genome.

Barbara McClintock first described transposable elements in maize (Zea mays) in the 1940s, work for which she received the Nobel Prize in Physiology or Medicine in 1983.

Tumor Suppressor Gene is a gene that normally restrains cell proliferation or promotes apoptosis, whose loss of function through mutation or silencing contributes to cancer development.

Unlike oncogenes, which are activated by gain-of-function mutations, tumor suppressor genes typically follow the two-hit hypothesis proposed by Alfred Knudson in 1971, requiring loss of function in both alleles before their protective effect is abolished. TP53, the most commonly mutated gene in human cancer, encodes a transcription factor that halts the cell cycle and triggers apoptosis in response to DNA damage. Mutations in TP53 are detected in roughly 50 percent of all human tumors, spanning cancers of the lung, colon, breast, and many other tissues.

Beyond TP53, the tumor suppressor category includes genes encoding DNA repair proteins such as BRCA1, cell cycle checkpoint regulators such as RB1, and apoptosis inducers such as PTEN.